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Abstract 
 
Objectives Methicillin-resistant Staphylococcus aureus (MRSA) is a major public health 
problem due to its multiple antibiotic resistance properties. Recently the emergence of MRSA 
have been described and investigated in animals. Through this study we aim to determine the 
prevalence of MRSA among Palestinian veterinary doctors, determine the molecular 
characteristics of these MRSA isolates and evaluate the risk of nasal MRSA carriage among 
those with direct contact with livestock .Methods Nasal swabs were obtained from 200 subjects 
including veterinary students and doctors from An-Najah National university and veterinary 
doctors working at the Ministry of Agriculture. at (). Data regarding animal exposure, 
information about professional contact and known MRSA risk factors were obtained from 
participants by designed questionnaire. Participants were screened for MRSA by standard 
microbiological techniques. Molecular analysis was done using Pulse Field Gel Electrophoresis 
(PFGE) in order to characterize the S. aureus isolates. Results: Nasal carriage of S. aureus was 
found in 28 of 200 specimens (14%) of which MRSA accounted for 4% (8 isolates). All 28 
strains of S. aureus were sensitive to vancomycin. 
MRSA resistances to other antibiotics used in this study were as follows: 89.2% to erythromycin, 
100% to ampicillin, 28.5% to Oxicillin, 14% to chloramphenicol, 39.2% to gentamycin. Four 
major types of PFGE patterns were identified (A, B, C and D) among MRSA strains. Three 
predominant PFGE types were recognized, Type A (37.5%). Type B (33.8%) and Type C 
(33.8%). One isolate with a unique PFGE pattern Type D (12.5%) was identified as a different 
clone. 
Conclusions MRSA colonization may be an occupational risk for veterinary professionals. As 
MRSA spread among community, changes in its epidemiology are certain. The micro flora of 
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humans and animals, are closely intertwined. MRSA is now a pathogen of domestic animals that 
can be transmitted between animals and humans. Accordingly, further scrutiny of the roles of 
animals in MRSA infection and colonization is required. The effect of routine contact with 
household pets on the global epidemiology of MRSA is still unknown. 
Key terms Antibiotic Resistance; MRSA; Veterinary Doctors. 
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Chapter One  
---------------------------------------------------------------------------------------------- 
INTRODUCTION 
Staphylococcus aureus is a Gram-positive, coagulase positive coccus, non-motile, non-spore 
forming bacteria. The golden appearance of this bacterium on blood agar is the etymological root 
of the bacteria's specific name as aureus means "gold" in Latin (Lowy, 1998). Staphylococcus 
aureus has been commonly noted to occur as a commensal organism, which usually exists 
without likely harmful effects, on the body surface or in the nasal passages of healthy humans 
and animals. Under certain conditions, such as weakness to immune system or injury to skin 
surfaces, a commensal organism may become opportunistic and be capable to causing infection. 
Clinical signs of infection in humans may range from light skin infections (pimples, boils and 
impetigo), to much more serious conditions such as post-operative wound infections and 
cellulites. S. aureus may also cause bacteremia, sepsis, meningitis and pneumonia (Kluytmans et 
al., 1997). 
In addition to human colonization by S. aureus, the organism can colonize many other animals, 
including horses, cats, birds, dogs, pigs, cattle and chickens (Weese. 2005). Antibiotics have 
been the first line of defense in treating clinical infection in both man and animals. Bacteria that 
are resistant to antibiotic treatment are a public health concern. 
 
During the past four decades, many strains of S. aureus have been evolved from controllable 
problem into a serious public health concern since they have become Methicillin-Resistant 
(David et al., 2010). The resistant bacteria produced penicillinase, an enzyme that breaks down 
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penicillin.  By 1961 the first case of MRSA infection was reported in England (Jevons et al., 
1961). Methicillin-Resistant Staphylococcus aureus (MRSA) strains are now prevalent 
worldwide in both human and veterinary medicine (Barber , 1990). 
The rapid spread of bacteria resistant to antimicrobials, although it is a global phenomenon, is 
seen to be higher in developing countries attributed mainly to misuse of antibiotics including use 
of prophylaxis (Palavecino,  2004). 
MRSA is a major cause of hospital-acquired infections worldwide (Jarvis et al. 2006), that’s why 
MRSA must be recognized now as one of the most common causes of infections acquired in the 
community (Graham et al., 2006). Transmission of MRSA from animals to staff tending to these 
animals appears to be an international problem, creating a new reservoir for community-acquired 
MRSA (CA-MRSA) in humans (Seguin et al., 1999). 
  The rise of a new zoonotic source of MRSA could have a severe impact on the epidemiology of 
CA-MRSA, and may have effects for the control of MRSA, especially in those countries that 
maintain a low prevalence by means of search and destroy policies (Lee, 2003).  
The objectives of this study were to evaluate the prevalence of MRSA among veterinary doctors 
in Palestine, and to determine the molecular characteristics of MRSA isolates by Pulsed-Field 
Gel Electrophoresis. 
 
 
 
 
 
 
3 
 
Aims and Objectives 
1. To evaluate the prevalence and molecular characteristics of (MRSA) among 
veterinary doctors and to estimate the impact of animal reservoir on human 
healthcare. 
 
2. To investigate if those in professional contact (veterinary doctors) with livestock 
are at higher risk for (MRSA) nasal carriage. 
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Chapter Two  
---------------------------------------------------------------------------------------------- 
LITERATURE REVIEW 
2. History of Staphylococcus aureus 
Staphylococcus aureus was discovered in the 1880s. During this time. S. aureus infection 
commonly caused painful skin and soft tissue conditions such as boils, scalded-skin syndrome, 
and impetigo. S. aureus is an important mammalian pathogen that has long been recognized for 
its ability to cause serious and invasive diseases. In 1878, Koch first noted that different diseases 
were caused by Gram-positive cocci depending on whether they formed pairs or chains. 
S. aureus was isolated in 1884 by German scientist Anton Rosenbach, who grews the two strains, 
S. aureus (“golden staph,” for the golden colonies  that forms on bacterial medium and S. albus 
(white colonies), in pure culture. In 1894, Van de Velde worked on the virulence determinants of 
S. aureus and on the protective immunogenicity effect of leucocytes and "humor", an old word 
for serum. 
 
2.1Characteristics 
S. aureus is a member of the Staphylococcaceae, a taxomic group which contains 33 other 
members (Freney, 1999).  S. aureus can be distinguished from other staphylococcal species on 
the basis of the gold pigmentation of colonies and positive results of coagulase, mannitol-
fermentation, and deoxyribonuclease tests (Wilkinson, 1997). The staphylococcal genome 
consists of a circular chromosome with prophages, plasmids, and transposons. Genes governing 
virulence and resistance to antibiotics are found on the chromosome, as well as the 
extrachromosomal elements (Clink et al., 1987). 
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S. aureus is normally found on the skin or in the nostrils of 20-30% of healthy individuals. S. 
aureus most commonly colonizes in the nostrils. Colonization is the state of S. aureus being 
present without causing any symptoms. When symptoms are present, it is called an infection 
(Graham et al., 2006). 
2.2 S. aureus Carriage and Disease 
Up to 20% of the human population is colonized by S. aureus as a commensal on the squamous 
epithelium of the anterior nares at any one time. However, it has been estimated that S. aureus 
can transiently colonize up to 60% of the human population (Foster, 2004). Nasal carriage of S. 
aureus is one of the major risk factors for S. aureus infection (Kluytmans, 1997).  
Human is a natural reservoir of S. aureus. Thirty to fifty percent of healthy adults are colonized, 
with 10 to 20 percent being persistently colonized (Roman et al., 1997). 
In healthy individuals, the carrier rate of S. aureus range between 15% to 35% and certain groups 
of individuals are more susceptible to S. aureus colonisation than others including health-care 
workers, nursing home inhabitants, prison inmates, military recruits and children (Sequin et al., 
1999). 
S. aureus is frequently isolated from the nostrils (anterior nares) and nose picking has been 
associated with S. aureus nasal carriage. Wertheim (Wertheim et al., 2004)  investigated the 
possible association between nose picking and S. aureus nasal carriage in a study of 238 
outpatients and 86 healthy hospital volunteers at a tertiary-care hospital’s ear, nose, and throat 
(ENT) clinic between June 2001 and May 2003 (Wertheim et al., 2004).  
S. aureus is a major pathogen in both nosocomial (hospital-acquired) and community-acquired 
infections worldwide, and according to the Centers for Disease Control and Prevention (CDC), is 
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one of the most common causes of human skin and soft tissue infections in the United States. 
Clinical signs range from minor skin conditions (e.g., pimples, boils and impetigo) to more 
severe disease such as cellulitis and postoperative wound infections. S. aureus can also cause 
pneumonia, bacteremia, meningitis, sepsis, and pericarditis. S. aureus is one of the most 
commonly identified bacteria that cause food poisoning and toxic shock syndrome (Wenzel and 
Perl, 1995). Individuals colonized with S. aureus are at increased risk for subsequent infections 
(Musher, 1994). 
S. aureus infection is a major cause of skin, soft-tissue, respiratory, bone, joint, and endovascular 
disorders. The majority of these infections occur in persons with multiple risk factors for 
infection (Lowry , 1998).  
S. aureus commonly causes boils, carbuncles, furuncles and impetigo, but after gaining access to 
the blood, may also be a major cause of endocarditis, osteomyelitis, pneumonia, toxic shock 
syndrome and septicemia (Klevens et al., 2007). 
 
2.3 Occurrence of Antibiotic Resistances to Beta-Lactam Drugs 
 Many people assumed with the discovery of antibiotics that the problems associated with 
infectious diseases were ended, but a new problem of antibiotic resistance emerged. Mutated 
forms of bacteria develop resistance to antibiotics and give rise to newer strains of infections 
(Aubrey et al., 2004). 
Many antimicrobial agents inhibit bacterial cell wall synthesis. These agents include β-lactam 
compounds such as penicillins (e.g. penicillin G, ampicillin and methicillin), cephalosporins and 
carbapenems. 
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S. aureus has also developed resistant mechanisms to β-lactam methicillin which was considered 
the drug of choice for treatment of s. aureus infections (Tenover, 2006). 
Methicillin is a semi-synthetic penicillin derivative and the resistance to this β-lactam drug 
among S. aureus is of great concern to medical and scientific personnel. MRSA has been 
reported as the most common cause of hospital-acquired infection for a number of years. 
Methicillin-resistant Staphylococcus aureus (MRSA) is a mutated form of bacteria resistant to 
antibiotics, known as beta-lactams, such as methicillin, oxacillin, penicillin, and amoxicillin, and 
the cephalosporins, such as cephalexin, and ceflactor (Tortora etal., 2003). 
Resistance to methicillin confers resistance to all penicillinase-resistant penicillins and 
cephalosporins. This high level of resistance requires the presence of the mec gene that encodes 
penicillin-binding protein 2a (Chambers, 1997).  
Although many methicillin-resistant strains appear to be descendants of a limited number of 
clones, some appear to be multiclonal in origin, suggesting the horizontal transfer of mec DNA 
(Archer et al., 1994).  The description "methicillin-resistant" was first used in 1961, based on the 
discovery of a human S. aureus infection in the United Kingdom that was resistant to methicillin 
(Moran et al., 2006). 
Penicillin was introduced in the 1940s and was used to treat S. aureus infections. Shortly after its 
introduction isolates of penicillin-resistant S. aureus were identified. Methicillin was first used in 
1959 to treat these penicillin-resistant strains of S. aureus and by 1961 methicillin-resistant 
strains were also being reported (Deresinski, 2005). The first methicillin-resistant case in Canada 
was reported by Low et al. in 1981 (Simor et al., 2001). For all MRSA infections, the annual 
incidence ranged between 18 and 25.7 cases per 100,000 population. The majority of these, 
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approximately 75% were skin and soft tissue infections. There is only limited information on 
morbidity and mortality of CA-MRSA (Hill and M., 2006). 
2.4 Factors Contributing to Increased Resistance 
Of the factors contributing to the rise in antibiotic resistant bacteria human misuse and abuse 
plays a critical role. Misuse includes indiscriminate prescription and dispensing of antibiotics 
and failure of patients to complete full course of antibiotic treatment. The microenvironment 
created by the constant use of antibiotics generate a selective pressure that selects for organisms 
able to survive and propagate in such an environment as the result of novel mutations, newly 
acquired genetic elements or inherent resistance as a  result of genetic diversity within a 
population (Tenover et al., 2001). 
 The use of antibiotics in food animals is thought to contribute heavily to the emerging resistance 
patterns in human pathogens. Antibiotics are used in animal husbandry to improve growth and 
maintain the health of livestock. Antibiotic use falls neatly into three main categories  :  
therapeutic, prophylactic and nutritive (Teuber, 1999).  
Many of the broad and narrow spectrum antibiotics used for therapeutic treatment of infected 
animals are the same as those used in humans. Since animals living so closely together are at risk 
of spreading disease, many livestock companies require their growers to feed animals low doses 
of antibiotics as a preventative measure. In fact, some 70% of antibiotics used in the United 
States are fed to animals that are not sick (Wallinga, 2004.).  
2.5 Hospital Acquired S. aureus  
Hospital-associated MRSA (HA-MRSA) infections occur most commonly in 
immunocompromised individuals in hospitals and healthcare centers. Risk factors for HA-
MRSA include hospitalization, surgery, dialysis, long-term care, indwelling devices, and history 
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of previous MRSA infection. To date, the majority of clinically significant MRSA infections are 
HA-MRSA (Klevens et al., 2007). Hospitalized patients and health-care workers have higher 
colonization rates than the general population (Parker and M., 1972). 
These gram-positive cocci can withstand environmental factors for extended periods allowing 
susceptible individuals to become infected through contact with contaminated objects, but  direct 
contact with persistently or transiently colonized people is the more important route of 
transmission )Goldmann et al., 1996). 
Such characteristics have made S. aureus the most common hospital acquired (nosocomial) 
pathogen with a wide array of virulence and resistance strategies (Sanford et al., 1994). 
2.6. Epidemiology of MRSA  
Epidemiological data on MRSA in Africa are scarce. The prevalence of MRSA was determined 
in eight African countries between 1996 and 1997 and was relatively high  50 % in Nigeria, 
Kenya, and Cameroon (Kesah et al., 2003) and below 10% in Tunisia and Algeria (Kesah et al., 
2003). 
In Algeria, the rate of MRSA increased to 14% in 2001 (Ramdani-Bouguessa et al., 2001) and 
the prevalence of PVL-positive MRSA has increase in 2006, these strains were resistant to 
multiple antibiotics, including gentamicin and ofloxacin (Ramdani-Bouguessa, et al., 2006).  
Approximately 1.5% of the U.S. population is currently thought to be nasally colonized by 
MRSA (Gorwitz et al., 2004).  
Farmers are also at risk of MRSA reservoirs. In a survey done on pig farmers in the Netherlands, 
23% (6/26) of pig farmers were colonized with MRSA, a rate that was 760 times higher than the 
general Dutch population; however, only 2 of 40 pigs tested were MRSA positive (Wulf et al., 
2006). Veterinary personnel are at increased risk of being MRSA reservoirs and zoonotic 
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transmission of MRSA and subsequent MRSA colonization should be considered an 
occupational risk for members of the veterinary healthcare team, particularly those in large 
animal practices. At  American College of Veterinary Internal Medicine (ACVIM) Forum 2005, 
6.5% of the attending veterinary personnel who volunteered to be tested were found to be 
colonized with MRSA (Weese et al., 2006).  
In that study, the volunteers provided a nasal swab and completed a questionnaire that identified 
potential risk factors for MRSA colonization. None of those who tested positive had a recent 
history of hospitalization or previous diagnosis of MRSA. Large animal practice was the only 
significant risk factor for MRSA colonization, with 12/271 (4.4%) small animal practice 
personnel colonized, and 15/96 (15.6 %) of large animal practice personnel colonized (Weese, et 
al., 2006). 
 
 
Figure 2.1: MRSA in Europe.  Staphylococcus aureus proportion of invasive isolates resistant 
to oxacillin (MRSA) in 2005 from European countries. Adapted from (EARSS Annual Report,  
2005) 
As it can be seen in figure 2.1, Scandinavia and the Netherlands are amongst the regions 
with the lowest MRSA prevalence. Holland has long been renowned for having a very stringent 
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MRSA control plan known as “search and destroy”. The isolation of MRSA positive patients, 
barrier nursing, high standards of hygiene and regular MRSA screening of patients and staff are 
the centre of this strategy, which has also been adopted by the Danish health service. The low 
prevalence of MRSA cases in these countries is thought to be attributed to this practical approach 
(Wertheim et al., 2004). The highest prevalence of MRSA were reported by Jordan, Egypt and 
Cyprus, where more than 50% of the invasive isolates were methicillin-resistant (Klevens et al., 
2007). 
 
2.7 Community Acquired MRSA (CA-MRSA) 
Until recently MRSA infections were primarily confined to the health care setting  (Seybold et 
al., 2006). The first report of community onset infections with MRSA came from Australia in 
1993 (Udo, 1993). Unlike HA-MRSA, which spread throughout the world slowly in the past 20-
30 years, CA-MRSA emerged only in the 1990’s and has rapidly moved throughout the world 
(Hawkey, 2008).  
Community-associated MRSA (CA-MRSA) infections occur in otherwise healthy people 
without a recent history of hospitalization or medical procedures, and are usually associated with 
skin and soft tissue infection. Risk factors for CA-MRSA include crowding, frequent contact, 
compromised skin, contaminated surfaces, shared items, and poor hygiene. To date the MRSA 
strain most commonly associated with CA-MRSA in humans is USA 300 (Naimi, 2003). 
In fact, CA-MRSA infections in U.S. outpatients increased seven-fold from 1999-2006.  CA-
MRSA may be adding to the overall number of infections in hospital populations rather than 
replacing HA-MRSA (Nicolle, 2006). CA-MRSA strains are SCCmec type IV, V, or VI, and 
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they contain the pvl gene. They are resistant to clindamycin and fluoroquinolones 
(Deurenbergand Stobberingh, 2008). 
 CA-MRSA infections have been identified often in the context of dramatically rising prevalence 
of MRSA in hospitals with MRSA isolation rates approaching 50% of S. aureus infections.  
Some features differentiate CA-MRSA from endemic hospital MRSA. HA-MRSA tends to be 
multiresistant, whereas CA-MRSA tends to be susceptible to narrow-spectrum non-beta-lactams 
such as clindamycin, trimethoprim-sulfamethoxazole (TMP-SMX), and tetracyclines (Adcock 
etal., 1998). Another distinguishing genetic feature of CA-MRSA is that a high percentage of 
strains carry genes for Panton-Valentine leukocidin (PVL). Genes for PVL are largely absent 
from HA-MRSA strains. Severe invasive diseases, such as necrotizing pneumonia and 
necrotizing fasciitis, appear to be more common with CA-MRSA than HA-MRSA. Furthermore, 
unlike HA-MRSA, which is considered an opportunistic pathogen, CA-MRSA causes infection 
in healthy, predominantly young hosts who have no predisposing co-morbidities (Fridkin et al., 
2005)  
2.8 MRSA carriage in veterinary staff 
There are various reports that have associated the emergence of antimicrobial resistance 
with the use of antimicrobials in companion animals, particularly fluoroquinolones and 
cephalosporins (Bywater , 2004). Several recent investigations have found that repeated 
exposure to antimicrobials may predispose human patients to infection with or carriage of 
MRSA (Lloyd, 2006). It is unlikely that daily antimicrobial exposure of veterinary staff when 
treating their patients i.e. through handling or applying topical and oral antimicrobial 
preparations, spillage, drawing up fluid antimicrobial suspensions into syringes can lead to the 
development of resistant strains amongst S. aureus commensal to human skin. Carriage rates of 
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MRSA in veterinary surgeons and related staff are high when such staff are sampled whilst on 
duty (Weese, 2004). 
2.9 Characterization of MRSA by Typing Techniques 
Strain typing is epidemiologically important for recognizing outbreaks of infection, detecting the 
cross-transmission of nosocomial pathogens, determining the source of the infection, and 
recognizing virulent strains. At present, there is no clear consensus regarding the best method to 
use for typing MRSA. In order to be effective, it should be highly discriminatory, reproducible, 
standardized, based on a stable feature, widely available, inexpensive and have performed 
satisfactorily in an epidemiological investigation (Tenover et al., 1994).  
Phenotypic methods such as biotyping, antibiogram, serotyping, phage typing and others 
frequently show lower discriminatory power ( Olive and Bean,. 1999). The shortcomings of 
phenotypically based typing methods have led to the development of typing methods based on 
the microbial genotype which minimize problems with typeability, reproducibility, and (in some 
cases) enable the establishment of large databases of characterized organisms.  
2.10 Pulsed Feild Gel Electrophoresis of whole chromosomal DNA 
Pulsed Feild Gel Electrophoresis (PFGE) is one of the genotypic techniques which is often 
considered the “gold standard” of molecular typing methods ( Olive and Bean 1999). PFGE has 
proven to be superior to most other methods for biochemical and molecular typing. It is highly 
discriminatory and superior to most methods for analysis of Escherichia coli, vancomycin-
resistant enterococci, S. aureus, Acinetobacter species, Pseudomonas aeruginosa, and 
Myobacterium avium (Arbeit et al., 1990, Arbeit et al., 1993, Barbier et al., 1996). PFGE was 
more efficient at differentiating strains of methicillin-resistant S. aureus than other methods 
tested (Prevost  et al., 1992, Saulnier et al., 1993).  
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This study is the first study to determine the prevalence, and molecular characterization of 
MRSA among Veterinarians in Palestine.  
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Chapter Three 
---------------------------------------------------------------------------------------------- 
 
Materials and Methods 
3.1 Study Design 
A cross sectional study was designed to find out the prevalence of MRSA nasal carriage among 
veterinary doctors as well as veterinary students in Palestine and then to determine the 
antimicrobial susceptibility testing and to characterize the Pulse-field gel electrophoresis 
genotype of the MRSA isolates. 
3.2 Clinical Specimen and Questionnaire information 
 Two hundred nasal swab were obtained from healthy veterinarians attached to the  Ministry of 
Agriculture as well as final year students at the Department of Veterinary Medicine at AN-Najah 
University, Palestine. About 200 nasal swabs were collected between June 2011 and October 
2011. The swabs were collected from all veterinarians whether they were in the administrative or 
field work. Along with the nasal swabs a questionnaire was filled by each participant prior to the 
sampling which included information about professional contact with specific animal species and 
information on recognized risk factors for MRSA carriage, such as previous hospitalization 
(within the last 6 months), antimicrobial therapy (within the last 6 months) and residence with a 
human health care worker. 
 
To collect the nasal specimen, a sterile cotton-tipped swab (BD Diagnostics, Sparks MD) was 
moistened with the solution in the transport container and then rotated for 10-15 seconds in the 
anterior nares (nostril). The swab was not inserted deeper than 1cm. The procedure was repeated 
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with the same swab on the other nostril then the swabs were placed in tubes of sterile culture 
medium and were then put in biohazard bags. The samples were stored overnight in the 
refrigerator and were plated the following morning. 
Samples were distributed as follows; in Tulkarem, the nasal swabs were collected from 
veterinary doctors of Ministry of Agriculture and AN- Najah University, veterinary Doctors and 
students were in the age group between 18 and 60 years. In Nablus, Hebron, Bethlehem, 
Ramallah, Qalqilia, Jericho, and Jenin, the nasal swabs were collected from veterinarians 
working in the units of veterinary and veterinary clinics. 
3.3 Microbiological identification of S. aureus  
The S. aureus isolates were identified based on standard laboratory phenotypic methods. 
All media were prepared in laboratory depending on the manufacturers instruction, this included 
mannitol salt agar (Himedia ,India), muller hinton agar (Biomark, India) and nutrient  broth 
(Himedia, India) and blood agar  prepared (Biomark, India). 
The specimens were plated on  mannitol salt agar. Plates were observed for the appearance of 
characteristic yellow colonies. Distinct, easily seen, yellow colonies were produced and  visible 
after 18-hour of incubation at 37 
0
C (aerobically) 
S. aureus was identified based on its Gram stain morphology, colonial morphology, and 
production of catalase and coagulase that are specific for S. aureus. (Gould et al., 2010).  
 
3.4 Antimicrobial Susceptibility Testing of MRSA Isolates 
The antimicrobial susceptibilities were tested by the disk diffusion method after overnight 
incubation at 37 °C on mueller-hinton agar plates according to the guidelines recommended by 
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the CLSI. The antimicrobials tested included Oxacillin (1μg), Vancomycin (30μg), Ampicillin 
(10μg), Erythromycin (15μg), Gentamycin (10μg), Ciprofloxacin (5μg), and Chloramphenicol 
(30μg) all from Oxoid, UK. 
Isolates with zone sizes 10 mm or less were considered as methicillin resistant.  
3.5 Storage of S. aureus isolates and MRSA 
All confirmed S. aureus isolate where stored in 16%v/v glycerol broth at -80 
0
C. the glycerol 
broth was prepared by adding 16 ml glycerol in 84 ml nutrient broth and distributed to 5 ml 
screw cap tubes. These tubes were then autoclaved at 115 
0
C for 20 minutes. The pH of the 
medium ranged from 7.2-7.6 at room temperature. Using a sterile swab, the entire growth of an 
overnight pure cultures was transferred to 5-ml of sterile glycerol broth and immediately stored 
at -80 
0
C. After 24 hours, the viability of the organism was checked by thawing the suspension at 
35 
0
C and inoculation of blood agar plates. 
3.6 Pulsed-Field Gel Electrophoresis for Typing MRSA 
The PFGE protocol was tried according to different methods such as the Matushek technique 
(Matushek et al., 1996), the standardized European technique (Murchan et al. 2003), and the 
Canadian standardized protocol (Mulvey et al. 2001). The Matushek has been validated and used 
for the present study, as it produced more consistent separation of the bands and better migration 
down the agarose gel.  The PFGE protocol described briefly as follows: 
3.6.1 Extraction of DNA 
A single colony of MRSA was grown in overnight in trypticase soy broth at 37 
0
C in a shaking 
incubator. Bacteria were harvested by centrifugation at 3000 r/min for 10 min. Cells were 
resuspended in 2.5 ml PIV buffer (1 mol/L NaCl, 10 mmol/L Tris–HCl, pH 7.4). A volume of 
0.5 mL of the cell suspension was mixed with 0.5 ml of 1.6% low-melting-point agarose (Sigma) 
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and pipetted into a 300 ml plug mold. The gel was solidified at 4 
0
C. Plugs were released into 1 
mL lysis solution (0.5 mg lysozyme, 10 mg RNase, 100 mg lysostaphin, 6 mmol/L Tris–HCL, 1 
mol/L NaCl, 10 mmol/L EDTA, 0.5% m/v Brij 58, 0.2% m/v deoxycholate, 0.5% m/v sodium 
lauryl sarcosine, pH 7.5) and incubated overnight at 37 
0
C. Lysis solution was replaced with 1 
mL ESP (100 mg proteinase K, 10 mmol/L Tris–HCl, 1 mmol/L EDTA, 1% SDS, pH 7.4) and 
plugs were incubated overnight at 50 
0
C. Plugs were washed twice in TE buffer (10 mmol/L 
Tris–HCl, 0.1 mmol/ L EDTA, pH 7.4) for 30 min each. They were then stored in fresh TE at 
4
0
C. A slice of the plug 2–4 mm wide was placed in 30 units of SmaI enzyme at 250 C overnight. 
Plug slices were washed for 1 h. in TE at 37
0
 C. SmaI digests the genome of S. aureus into 15–20 
restriction fragments with sizes ranging from 10 to 700 kb. The enzyme recognition sequence is 
CCC GGG. 
3.6.2 Electrophoresis and Imaging  
Plugs were inserted into the wells of a 1% agarose prepared in 0.5× TBE buffer (0.9 mol/ L 
Trizma base, 0.9 mol/ L boric acid, 20 mmol/ L EDTA, 1 LdH2O). Lambda PFG markers (50 
mg/mL) (50–1000 kb) (New England BioLabs, USA) were inserted into appropriate wells in the 
gel. Inter gel comparison was done via the Bionumerics 3.0 software. Wells were over layered 
with low-melting-point agarose and allowed to solidify at 4 
0
C. Gel was placed in the PFGE 
machine (CHEF DR III) (Bio-Rad Laboratories, Hercules, California, USA) adjusted with the 
following conditions: temperature, 14 
0
C;run time, 21 h; volts, 200 V (6 V/cm); and pulse time, 
initial switch time 1 s and final switch time 20 s. Gels were stained with 0.5 mg/mL ethidium 
bromide and gel images were digitized through a UV gel image acquisition camera (Gel Doc 
XR; Bio-Rad Laboratories). 
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DNA fragments on each gel were normalized using the molecular weight standards run on the 
gel. Dendrogram were generated for combined gel images. A 1.00% band tolerance and an 
optimization of 1% were selected for use during comparisons of DNA profiles. Cluster analysis 
was performed by the unweighted pair-group method using arithmetic averages and DNA 
relatedness was calculated based on Dice coefficient (Struelens etal. 1992).  
The established criteria or guidelines proposed by Tenover et al. were used for the  interpretation 
of PFGE (Tenover et al, 1997). With these guidelines, a banding pattern difference of more than 
three bands were considered different strains. 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
Chapter Four 
---------------------------------------------------------------------------------------------- 
Results 
4.1 Epidemiological Data 
A total of 200 veterinarian and student from 8 agriculture units  participated in this project. Data 
were collected using designed questionnaire that include information regarding the participant 
health and work history, job description, and exposure to animals.   196 subjects were males and 
4 females as shown in table 1. Only 3% of veterinarians reported to have lung problems, 2.5% 
heart problems and 1.5% having chronic medical problems. None of the participants were 
diagnosed with clinical MRSA infection in the past 12 months. 
Different variables seemed to be associated with carrying MRSA such as examining and treating 
cattle, sheep, horses, and the number of animals they contact with daily. On the other hand, 
length of employment did not seem to be associated with carrying MRSA, even among 
respondents who had worked more than 18 years on field.  
The prevalence of MRSA among veterinary doctors has been found to be   4%. Among as 200 
samples 28 samples were positive for S. aureus (14 %) out of which 8 were MRSA. In Nablus; 
34 (17%) nasal swabs were collected from veterinary doctors, 11 (5.5%) of them were colonized 
with S. aureus and 5 (2.5%) of them were MRSA. In Tulkarem; 45 (22.5%) nasal swabs were 
collected from veterinary doctors and students and of these 7 (3.5%) were colonized with S. 
aureus and none of them were MRSA. In Jenin 14 (7%) nasal swabs were collected from 
veterinary doctors none of them were S. aureus nor MRSA. In Hebron 45 (22.5%) nasal swabs 
were collected from veterinary doctors 10 (5%) were colonized with S. aureus and from them 3 
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(1.5%) were MRSA. In Qalqilia 15 (7.5%) nasal swabs were collected from veterinary doctors 
and none of them were S. aureus nor MRSA. In Bethlehem 14 (7%) nasal swabs were collected 
from veterinary doctors and none of them were S. aureus nor MRSA. From Ramallah 20 (10%) 
nasal swabs were collected from veterinary doctors and none of them were S. aureus nor MRSA 
and from Jericho 13 (6.5%) nasal swabs were collected from veterinary doctors and none of them 
were S. aureus nor MRSA. The highest prevalence of MRSA isolates were seen in Nablus (15%) 
and Hebron (10.3%) districts. However, the prevalence of MRSA was absent in Bethlehem, 
Ramallah, Jenin, Tulkarem, Jericho, and Qalqilia. The average age of the participants was 42.7 
years old.  Antibiotic use was reported in  3% of veterinary doctors and  97% of them did not use 
any antibiotic within 7 days before collecting nasal swabs as shown in  Table 4.1 
Table 4.1: Characteristics of the Veterinary doctors Population and MRSA Prevalence 
Variable  Total Number of 
 Veterinarians 
Percentage of MRSA positive 
Gender Male 
Female             
196        
4
 
4% 
0% 
Lung problems Yes 
No                    
6   
194
0% 
4% 
Heart problem Yes       
No  
5           
195 
0% 
4% 
Chronic medical 
problem 
Yes       
No  
3          
197 
0% 
4% 
antibiotics in the past 
7 days 
Yes       
No 
6          
194 
0 
4% 
Length of 
employment (years) 
< 3 
4-18 years 
> 18 years 
0% 
2.5% 
1.5% 
Spent time in a jail Yes      
 No     
4  
196 
 
0% 
4% 
Diagnosed with 
MRSA in the past 12 
months 
Yes       
No         
0 
200 
0% 
4% 
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City: 
Nablus 
Tulkarem 
Jenin 
Hebron 
Qalqilia 
Bethlehem 
Ramallah 
Jericho 
 
N=34 
N=45 
N=14 
N=45 
N=15 
N=14 
N=20 
N= 13 
 
14%                      
0% 
0% 
6.6% 
0% 
0% 
0% 
0% 
 
All MRSA carriers in this study have had recent or regular contact with cows and sheep and all 
of them were males.  
4.2 Antibiotic Sensitivity Profile of the S. aureus Isolates 
The resistant, susceptible, and intermediate isolates to the most common used antibiotics against 
S. aureus are shown in Table 4.2. Eight out of 28 S. aureus isolates were resistant to oxacillin 
and considered to be MRSA. Twenty five (89.28%) of S. aureus isolates showed resistant to 
erythromycin, one was sensitive and two were intermediate to erythromycin. All the twenty eight 
S. aureus isolates were resistant to ampicillin. Eleven showed resistant to chloramphenicol, 
fifteen were sensitive and 2 were intermediate. All were sensitive to vancomycin. Six of S. 
aureus isolates were gentamycin resistant, twenty two were gentamycin sensitive.  
Table 4.2: Antibiotic profile of the twenty eight S. aureus isolates, and percentage of isolates 
sensitivity and resistant. 
Antibiotic Resistant  Susceptible Intermediate 
 number % number % number % 
Oxacillin 8 28.5 19 67.8 0 0 
Erythromycin 25 89.2 1 3.5 2 7.1 
Ampicillin 28 100 0 0 0 0 
Chloramphenicol 11 39.2 15 53.5 2 7.1 
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Vancomycin 0 0 28 100 0 0 
Gentamycin 6 21.4 22 78.5 0 0 
 
All the eight MRSA isolates tested exhibited resistance to oxacillin, ampicillin and erythromycin.  
The 8 MRSA isolates were assigned to 1 of 4 antibiotic profiles based on their susceptibilities to 
the various antibiotics used.  
Type 1 comprised of three isolate and were resistant to oxacillin, ampicillin, erythromycin and 
gentamycin, Type 2 comprised of three isolates and were resistant to Oxacillin, ampicillin, 
erythromycin, gentamycin and chloramphenicol. Type 3 had 1 and showed a resistant pattern of 
Oxacillin, ampicillin, erythromycin and type 4 had one which showed a resistant pattern of 
oxacillin, ampicillin, erythromycin and chloramphenicol as shown in Table 4.3. 
Table 4.3: Resistant pattern of MRSA to various antibiotic groups isolates 
Resistant Pattern Number of isolates Percentage of isolates Antibiogram 
type 
Oxa,Amp,Ery,Gen, 
Chl 
3 1.5% 1 
Oxa, Amp, Ery 1 0.5% 2 
Oxa, Amp, Ery, Gen 3 1.5% 3 
Oxa, Amp, Ery, Chl 1 0.5% 4 
Oxa= oxacillin, Amp= ampicillin, Ery=erythromycin, Gen= gentamycin, Chl= 
chloramphenicol, Vanco= vancomycin 
 
Most MRSA isolates were multi-resistant to more than three antibiotics including; ampicillin, 
erythromycin, oxacillin, and gentamycin as seen in Figure 5. 
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Figure 4.1: Antibiotic susceptibility testing showing oxacillin resistant and multi drug 
resistance 
 
4.3 Molecular Typing 
Pulsed Field Gel Electrophoresis Results  
Genetic investigation using Pulsed field gel electrophoresis were carried out for typing MRSA 
isolates. PFGE grouped the 8 isolates into 4 types A, B, C and D (Figure 4.2), All the MRSA 
isolates generated about 14-18 amplification fragments ranging from50-1000  bp  and were 
easily comparable 
PFGE type A was the most common pattern seen in Nablus which includes 3 isolates PFGE type 
B included two isolates; one was from Nablus and the other from Hebron. PFGE type C had two 
isolates from Hebron. PFGE type D was seen in 1 isolate only. 
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Figure 4.2: PFGE types of 8 MRSA isolates 
Lane 1.  Molecular weight marker, lane 2-9 MRSA isolates, PFGE type A (2, 6, 9), PFGE type B 
(3, 7), PFGE type C (4, 8), PFGE type D (5). Lane 10 positive control ATCC (25923).  
 
A dendrogram showing estimates of the percent similarities among the 4 types identified by 
PFGE as shown in figure 4.3. 
 
Figure 4.3: PFGE dendrogram showing percentage similarities of MRSA isolate. Data was 
analyzed using BioNumerics Version 3.0. Dendrogram were derived from the 
Unweighted pair group method using arithmetic averages (UPGMA) and based on Dice 
coefficients. Band position tolerance and optimization were set at 1.00%. 
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Chapter Five 
----------------------------------------------------------------------------------------------
Discussion 
S. aureus is one of the most commonly diagnosed pathogens. It causes diseases ranging from 
self-limiting food poisoning to life-threatening septicemia and pneumonia. Control and treatment 
measures for this organism are complicated by its remarkable adaptation ability to its 
environment especially through the acquisition of antibiotic resistance determinants. The most 
alarming trend in recent years was the acquisition of methicillin resistance that turned the use of 
β-lactam antibiotics into useless for controlling S. aureus infections. Among Hospital-based 
infection by MRSA, the ratio is continuously increasing in most countries but there are 
considerable differences in MRSA prevalence among individual countries. The MRSA rate was 
low (2.0%) in Netherlands (de Sousa et al. 1998) and 1.8% in Switzerland (Kotilainen et al. 
2003) and high MRSA rates > 50% in Italy, Portugal, and > 30% in Greece and Turkey (Gosbell 
et al. 2001). These variations of MRSA may be attributed to variations in patient populations, the 
biological characteristics of the S. aureus strains and infection control practices (Orrett and Land 
,2006). In a study carried out in Palestine by Adwan et al  in 2005 that include a total of 321 
clinical isolates of S. aureus from different patients, have found that the prevalence of MRSA 
was 8.7 % and in another study done on 72 health-care workers found that 10/72 (13.9%) where 
colonized by MRSA  (Kaibni  et al., 2009). 
Among community based colonization, the rate of MRSA is considered low (Salgado et al., 
2003). In the Netherlands, the prevalence of MRSA upon admission to a hospital was 0.03% 
(Wertheim et al., 2004). Even in countries with a high prevalence of MRSA, e.g. the USA and 
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Portugal, carriage rates in the general population are only 0.2–3% [Wertheim et al., 2004). 
Recently, a shift in the epidemiology of MRSA infection has been documented, whereby 
community-associated (CA)-MRSA infections have become more common (Faria  et al., 2005; 
Zetola  et al., 2005). 
 In a study done in Palestine by Kaibni  et al, 2009 843 participant without a history of 
hospitalization found that 2.0% where colonized by MRSA.  
This study represents the first study in Palestine that studied the MRSA colonization in 
veterinary personnel. Although a control group was not included, the prevalence in veterinary 
personnel (4%) was higher than previously reported rates for community-based colonization 
(Kaibni  et al, 2009). All 8 MRSA carriers in our study have had recent or regular contact with 
large animals such as cows and sheep which suggest that they could have acquired MRSA from 
the animals they deal with.  Five MRSA isolates were from Nablus and 3 from Hebron. Our 
results suggest an increased risk for veterinary professionals. Further investigation is required to 
more accurately identify the occupational risk. The prevalence of MRSA usually varies among 
different geographical regions and between different institutions in a given area (Durmaz et al., 
1997).  
All of the 28 S. aureus isolates including the 8 MRSA were resistant to ampicillin which is in 
concordance with previously reported studies. (Hamid et al., 2011; Albrich,and  Harbarth, 
2008. ). MRSA are also resistant to other group of antibiotics such as erythromycin. About 89% 
of the S. aureus isolates were resistant to erythromycin including the 8 MRSA (100% MRSA 
resistant to erythromycin) and about 7% were reported to be intermediate (Table 2 and 3).  In a 
study carried out by Udo etal., they have reported that the prevalence of erythromycin resistance 
MRSA increased from 66% in 1994 to 88% in 2004 (Udo et al., 2006). 
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The MRSA strains have variable sensitivity to other antimicrobials such as chloramphenicol, and 
gentamicin. Half of MRSA isolates were resistant to chloramphenicol and (75%) resistant to 
gentamycin (Table 7). In a study done in India they found out that about 40–50% of MRSA were 
resistant to chloramphenicol and gentamicin (Vidya et al., 2010).  All S. aureus including MRSA 
isolates were sensitive to vancomycin. 
The 8 MRSA isolates were assigned to 1 of 4 antibiotic profiles based on their susceptibilities to 
the various antibiotics used. All MRSA isolates were resistant to at least 3 different antibiotics 
including oxacillin and were considered multi drug resistant.   
The PFGE type distribution was as follows: Type A from Nablus included 3 MRSA isolates, 
type B comprised 2 isolates from Hebron and interestingly type C had 2 isolates; one from 
Hebron and the other from Nablus. This similarity between the isolates could be explained by the 
fact that regular gathering takes place between Palestinian veterinarians such as workshops and 
other official meetings and transmission could have taken place during those gatherings and not 
through common animal source. In comparison to our study, a common  PFGE similarity 
patterns of MRSA were found in a study carried out on veterinarians attendees at an international 
veterinary conference (Beth et al., 2006). 
A comparison of PFGE results with antibiograms indicated that considerable agreement obtained 
between both techniques, i.e. PFGE type A (strain numbers 2, 6 and 9 Figure 3,4) had same 
antibiogram pattern (Type 3), and were resistant to oxacillin, ampicillin, erythromycin and 
gentamicin (Table 7). PFGE type C (strain numbers 4 and 8 Figure 3,4) had same antibiogram 
pattern (Type 1), and were resistant to oxacillin, ampicillin, erythromycin, gentamicin and 
chloramphenicol (Table 2). 
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As MRSA prevalence increase in the community, changes in its epidemiology are certain. The 
lives of humans and animals, and their microflora, are closely intertwined. MRSA is now a 
pathogen of domestic animals that can be transmitted between animals and humans. 
Accordingly, further studies should be carried out on the prevalence of MRSA in animals as well 
as veterinaries to find out the extent of MRSA transmission between them. While job related 
exposure to animals may be a risk factor for MRSA colonization, the effect of regular contact 
with house pets on the global epidemiology of MRSA is still unknown. 
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Appendices 
Enrollment Questionnaire 
Thank you for participating in this study. This questionnaire is intended to gather 
information on your current and past contact with animals and other potential risk factors for 
infection with methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that can cause a 
variety of diseases, and should only take a few minutes to complete. Please answer the questions 
to the best of your knowledge and check the appropriate boxes. All responses will remain 
confidential. 
DEMOGRAPHICS 
1. What is your gender? 
Male 
Female 
2. Your age 18-34                      35-59            > 60 
3. What is your city? 
Tulkarem                   Jenin           Nablus                Kalkilia              Ramallah 
Jericho               Betlahem               Hebron 
MEDICAL HISTORY AND EXPOSURES 
4. Do you have a medical history of any chronic lung problems such as 
asthma or emphysema? 
       Yes                                                              No 
5. Do you have a medical history of any heart disease or vascular disease? 
       Yes                                                             No 
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6. Do you have a medical history of any other chronic medical problems including diabetes, 
kidney disease, cancer, blood disease, or diseases that weakens the immune system? 
        Yes                                                                No 
7. Do you take medications such as anti-cancer drugs, corticosteroids like 
prednisone, or other drugs that weaken the immune system? 
        Yes                                                              No 
8. Have you taken antibiotics in the past 7 days? 
Yes                                                                  No  
9. Have you spent time in a jail or other correctional facility in the previous 6 months? 
    Yes                                                                    No 
10. Have you or any family members visited a patient in the hospital in the previous 
12 months? 
         Yes                                                                    No 
11. Do you or any immediate family members work in a hospital or long-term care facility? 
         Yes                                                                    No  
12. Have you previously been diagnosed with a methicillin-resistant Staphylococcus 
aureus infection? 
         Yes                                                                     No 
13. Do you have regular contact with those animals? 
Cattle                               sheep                           horses                         Pigs 
14. Have you been diagnosed with a skin or soft tissue infection (such as infection of the muscle) 
in the previous 12 months? 
Yes                                                                    No 
 
15. How long have you been working as veterinarian? 
    <3 years                  3-18 years               18<years 
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16. What is the animal type which you have great contact with it? 
Large animal                        Small animals 
 
17. Do you were masks?   Yes                                   NO 
 
Bacterial culture media 
Different bacterial culture media were used during this study. These media are presented in 
Table1 
Table1:  
Media Manufacture 
Mannitol salt agar Himedia (India) 
Muller Hinton agar Biomark ( India) 
Transport media Aptaca (USA) 
Tryptic Soy broth. Himedia (India) 
Thioglycollate broth Himedia (India) 
 
Reagents 
Reagents are presented in Table2 
Table2:  Reagents and materials employed in the study 
Reagent Manufacture 
Gram stain reagents Sigma (USA) 
Hydrogen peroxide Sigma (USA) 
DNA molecular weight marker (50bp 
ladder 
Promega (USA) 
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Equipments 
Table3: Apparatus and special equipments that were used in the study 
  
Thermal cycler  Eppendorf 
Research pipettes    Eppendorf 
Microfuge tube – 1.5 ml  Eppendorf 
PCR microfuge tube, 0.2 ml  Eppendorf 
Microwave oven  LG 
Hoefer Shortwave UV light Table, (Trans 
illuminator) 
Hoefer (USA) 
 
Digital Camera) Cannon (Japan 
Power supply  Bio-Rad (USA) 
Micro-Centrifuge   Sanyo (UK) 
Electrophoresis set-up  Bio-Rad (USA) 
 
 
 
 
 
Master Mix Promega (USA) 
Primers TIB MOLBIOL (Germany ) 
Antibiotic disks  Himedia( India), Oxoid (UK 
Ethidium bromide   Sigma (USA) 
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 ٗاّزشبسٕب ثِٞ اىزشخٞض اىجضٝئٜ ىجنزٞشٝب اىَن٘ساد اىزٕجٞٔ اىعْق٘دٝٔ اىَقبٍٗٔ ىيَٞثٞسٞيِٞ  دساسٔ ر٘ضخ
 اطجبء اىجٞطشٓ فٜ فيسطِٞ 
  :  سٗصاُ سٍٗو ف٘صٛ عزٞيٜاعذاد
  :  د. دبرٌ عٞذٓاشراف 
 ملخص: 
ّزٞجٔ ىخبطٞٔ ٕزا  سئٞسٞخ ٍشنيخ طذٞخ  َٞثٞسٞيِٞاىَقبٍٗخ ىي اىَن٘ساد اىعْق٘دٝخ اىزٕجٞخرَثو  :الاهذاف
اىَن٘ساد اىعْق٘دٝخ قَْب ثجذث اّزشبس ٗخطش اّزقبه اىْ٘ع ٍِ اىجنزٞشٝب  فٜ ٍقبٍٗٔ  اىَضبداد اىذٞ٘ٝٔ. 
  َٞثٞسٞيِٞ ٍِ اّف الاشخبص اىزِٝ ىذٌٖٝ ارظبه ٍْٖٜ ٍع اىَ٘اشٜ. اىَقبٍٗخ ىي اىزٕجٞخ
اىذٞ٘اّبد اىزٜ  اّ٘ف الاطجبء اىجٞطشِٝ ٍٗعيٍ٘بد عِ ٍسذبد ٍِ اىطشٝقٔ ٗالاسي٘ة : رٌ اىذظ٘ه عيٚ 
 ٍَِٞثٞسٞيِٞ اىَقبٍٗخ ىي يَن٘ساد اىعْق٘دٝخ اىزٕجٞخى ٝزعشضُ٘ اىٖٞب ٗ ع٘اٍو اىخط٘سٓ  اىَعشٗفخ
ٍذُ   8اىضساعخ اىَْزششٓ فٜ  ٗٗدذاد اىْجبح ٍِ جبٍعخ عْٞٔ   )112 = N(ذٞث رٌ جَع  اىَشبسمْٞ
اىَن٘ساد  ىينشف عِ اىقٞبسٞخ اىَٞنشٗثٞ٘ى٘جٞخ ث٘اسطخ رقْٞبد  سمِٞ رٌ فذض  اىَشبفيسطْٞٞٔ. مزىل 
 .ٗٗطفٖب َٞثٞسٞيِٞ اىَقبٍٗخ ىي اىعْق٘دٝخ اىزٕجٞخ
 ٪.4اشخبص دبٍيِٞ  ىيَن٘ساد اىعْق٘دٝخ اىزٕجٞخ اىَقبٍٗخ ىيَٞثٞسٞيِٞ  ثْسجخ اّزشبسقذسٕب  8: ٗجذّب النتائج
%  2.98ّست اىجنزٞشٝٔ اىعْق٘دٝٔ اىَقبٍٗٔ مبّذ  اُاسزخذٍْب رقْٞٔ اىَضبداد اىذٞ٘ٝٔ ّٗزج عْٖب 
% 2.93% ىيني٘سٍفْٞٞن٘ه, ٗ 41سبسٞيِٞ, ٗ مىلاٗ %  5.82% ىيلاٍجٞسٞيِٞ, ٗ  111ىلاسٝثشٍٗٞسِٞ, ٗ 
ٍِ اىعْٞبد مبّذ ٍقبٍٗٔ ىيجْٞزبٍٞسِ. اسزخذٍْب رقْٞخ ّجض اىنٖشثبئٜ ٕلاً فٞيذ اىزٜ ّزج عْٖب اسثع اّ٘اع 
اىزٛ اّزشش عْذ طجٞت ثٞطشٛ    )5.21(ب ٪)  اىزٛ اّزشش ثْبثيس، ّ٘ع 5.73( إٔ٘ ّ٘ع مبُ الامثش شٞ٘عب 
٪)  الامثش اّزشبسا ثِٞ اطجبء ثٞطشح اىخيٞو اٍب 52(جٗادذ فٜ ّبثيس ٗطجٞت ٗادذ فٜ اىخيٞو  . ٗاعزجش ّ٘ع 
 فقذ  اّزشش عْذ طجٞت ٗادذ فٜ ّبثيس. د اىْ٘ع
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ٕٜٗ ٍِ اىَخبطش اىَْٖٞٔ ىيعبٍيِٞ فٜ  اىجٞبطشٓ ّ٘فرسزعَش ا ىيَٞثٞسيِٞٓ داىجنزٞشٝب اىعْق٘دٝٔ اىَضب قذ رنُ٘
دذٗد  اىَجزَع اىٚ فٜ  ٓ ىيَٞثٞسيِٞدىجنزٞشٝب اىعْق٘دٝٔ اىَضبٍْٖخ اىطت اىجٞطشٛ. مَب ادٙ  اّزشبس ا
ٜ َٝنِ أُ ىيذٞ٘اّبد اىَْضىٞخ ٗ اىز خاىََشض ىيَٞثٞسيِٞ بدٓاىجنزٞشٝب اىعْق٘دٝٔ اىَضفٜ عيٌ الأٗثئخ.  ادرغٞش
اىجنزٞشٝب ّقو  اىذٞ٘اّبد فٜ ىذٗس ل دبجخ إىٚ ٍضٝذ ٍِ اىزَذٞضىرْزقو ثِٞ اىذٞ٘اّبد ٗاىجشش. ٗفقب ىزىل، ْٕب
 الادظبئٞبد دستٗرىل  ٍع اىذٞ٘اّبد اىَْضىٞخ الأىٞفخ دزنبكرأثٞش الا ٗدساسخ ٓ ىيَٞثٞسيِٞداىعْق٘دٝٔ اىَضب
ساد اىعْق٘دٝٔ اىَقبٍٗٔ ىيَٞثٞسٞيِٞ ٍِ اىذٞ٘اّبد الاىٞفٔ ٗاىَْضىٞٔ ىعبىَٞخ, دساسخ ربثٞش اّزقبه اىَن٘ا اى٘ثبئٞٔ
 .ٍجٖ٘لا لا صاه 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
